Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. EIDD-2801 is an orally bioavailable isopropylester cytidine analog being investigated to treat COVID-19. Reference standards of Molnupiravir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Molnupiravir
Catalogue No.:PA 13 2380000
CAS :
Molecular Formula : C13H19N3O7
Molecular Weight : 329.31
N4-Hydroxycytidine
Catalogue No.:PA 13 2381000
Molecular Formula : C9H13N3O6
Molecular Weight : 259.22
1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
Catalogue No.:PA 13 2381001
1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one
Catalogue No.:PA 13 2381002
((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381003
Molecular Formula : C13H19N3O6
Molecular Weight : 313.31
((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381004
Molecular Formula : C13H18N2O7
Molecular Weight : 314.29
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381005
Molecular Formula : C9H16O6
Molecular Weight : 220.22
((2R,3S,4R,5R)-3,4-Dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381007
2',3'-Isopropylidenecytidine
Catalogue No.:PA 13 2381008
Molecular Formula : C12H17N3O5
Molecular Weight : 283.28
((3aR,4R,6R,6aR)-6-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Catalogue No.:PA 13 2381006
Molecular Formula : C16H23N3O6
Molecular Weight : 353.38
Uridine-5-methylpropanoate-4-oxime
Catalogue No.:PA 13 2381009
((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Acetate
Catalogue No.:PA 13 2381010
Molecular Formula : C11H15N3O7
Molecular Weight : 301.26
[13C,15N2]-N4-Hydroxycytidine
Catalogue No.:PA STI 089182
Molecular Formula : C813CH13N15N2O6
Molecular Weight : 262.2
Beta-d-N4-Hydroxycytidine-D2
Catalogue No.:PA STI 089278
Molecular Formula : C9H11D2N3O6
Molecular Weight : 261.23
N(4)-Hydroxycytidine (Hydrate Salt)
Catalogue No.:PA 13 2381011
Molecular Formula : C9H15N3O7
Molecular Weight : 277.23
N-Butyl Molnupiravir
Catalogue No.:PA 13 2381012
((3aR,4R,6R,6aR)-6-(4,6-Bis(hydroxyamino)-2-oxo-5,6-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate
Catalogue No.:PA 13 2381013
Molecular Formula : C16H26N4O8
Molecular Weight : 402.4
(2R,3R,4R,5R)-2-(4-(Hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-5-((isobutyryloxy)methyl)tetrahydrofuran-3,4-diyl bis(2-methylpropanoate)
Catalogue No.:PA 13 2381014
Molecular Formula : C21H31N3O9
Molecular Weight : 469.49
Uridine, 4-oxime, 5′-(2-methylpropanoate)
Catalogue No.:PA 13 2381015
((2S,3R,4S,5S)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381016
((2R,3S,4R,5S)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
Catalogue No.:PA 13 2381017
((3aR,4R,6R,6aR)-6-(2,4-bis(Hydroxyamino)pyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl Isobutyrate
Catalogue No.:PA 13 2381018
Molecular Formula : C16H26N4O7
Molecular Weight : 386.41
((3aR,4R,6R,6aR)-6-(2,4-dioxo-3,4-Dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Catalogue No.:PA 13 2381019
Molecular Formula : C16H22N2O7
Molecular Weight : 354.36
Molnupiravir (IPRSM017)
Catalogue No.:PA IPRSM017
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
